SESSINE NAJJAR
Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease CLIFTON, NJ NPI 1497862429
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease NJ Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$12,556.75
- Category: General Payments
- Program years: PY2018–2024
- Record count: 887
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,630.17 across 102 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,608.45 | 100 |
| Education | $21.72 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $471.70 | 29 |
| ViiV Healthcare Company | $245.77 | 18 |
| Merck Sharp & Dohme Corporation | $197.01 | 12 |
| Novo Nordisk AS | $93.86 | 5 |
| Insmed, Inc. | $81.75 | 5 |
| Cumberland Pharmaceuticals, Inc. | $80.86 | 5 |
| GlaxoSmithKline, LLC. | $62.52 | 4 |
| PFIZER INC. | $58.61 | 3 |
| Amgen Inc. | $54.82 | 3 |
| EMD Serono, Inc. | $46.27 | 3 |
| ABBVIE INC. | $42.19 | 3 |
| Shionogi Inc | $35.15 | 2 |
| Lilly USA, LLC | $32.26 | 2 |
| Phathom Pharmaceuticals, Inc. | $31.49 | 2 |
| Grifols USA, LLC | $22.39 | 1 |
| Janssen Pharmaceuticals, Inc | $16.60 | 1 |
| Napo Pharmaceuticals Inc | $15.45 | 1 |
| MannKind Corporation | $14.14 | 1 |
| Acerta Pharma LLC | $13.78 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $13.55 | 1 |
By program year
Records — PY2024 (102)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.